R01 CA210273/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2016	1
2017	9
2018	8
2019	9
2020	11
2021	9
2022	1
2023	2
2024	2

1

Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome.

Lee Y, Kamada N, Moon JJ. Lee Y, et al. Adv Drug Deliv Rev. 2021 Dec;179:114021. doi: 10.1016/j.addr.2021.114021. Epub 2021 Oct 26. Adv Drug Deliv Rev. 2021. PMID: 34710529 Free PMC article. Review.

2

Designer vaccine nanodiscs for personalized cancer immunotherapy.

Kuai R, Ochyl LJ, Bahjat KS, Schwendeman A, Moon JJ. Kuai R, et al. Nat Mater. 2017 Apr;16(4):489-496. doi: 10.1038/nmat4822. Epub 2016 Dec 26. Nat Mater. 2017. PMID: 28024156 Free PMC article.

3

Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy.

Sun X, Zhang Y, Li J, Park KS, Han K, Zhou X, Xu Y, Nam J, Xu J, Shi X, Wei L, Lei YL, Moon JJ. Sun X, et al. Nat Nanotechnol. 2021 Nov;16(11):1260-1270. doi: 10.1038/s41565-021-00962-9. Epub 2021 Sep 30. Nat Nanotechnol. 2021. PMID: 34594005 Free PMC article.

4

Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis.

Lee Y, Sugihara K, Gillilland MG 3rd, Jon S, Kamada N, Moon JJ. Lee Y, et al. Nat Mater. 2020 Jan;19(1):118-126. doi: 10.1038/s41563-019-0462-9. Epub 2019 Aug 19. Nat Mater. 2020. PMID: 31427744 Free PMC article.

5

Non-viral COVID-19 vaccine delivery systems.

Park KS, Sun X, Aikins ME, Moon JJ. Park KS, et al. Adv Drug Deliv Rev. 2021 Feb;169:137-151. doi: 10.1016/j.addr.2020.12.008. Epub 2020 Dec 17. Adv Drug Deliv Rev. 2021. PMID: 33340620 Free PMC article. Review.

6

Engineering patient-specific cancer immunotherapies.

Scheetz L, Park KS, Li Q, Lowenstein PR, Castro MG, Schwendeman A, Moon JJ. Scheetz L, et al. Nat Biomed Eng. 2019 Oct;3(10):768-782. doi: 10.1038/s41551-019-0436-x. Epub 2019 Aug 12. Nat Biomed Eng. 2019. PMID: 31406259 Free PMC article. Review.

7

Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel.

Han K, Nam J, Xu J, Sun X, Huang X, Animasahun O, Achreja A, Jeon JH, Pursley B, Kamada N, Chen GY, Nagrath D, Moon JJ. Han K, et al. Nat Biomed Eng. 2021 Nov;5(11):1377-1388. doi: 10.1038/s41551-021-00749-2. Epub 2021 Jun 24. Nat Biomed Eng. 2021. PMID: 34168321 Free PMC article.

8

Bioinspired nucleic acid structures for immune modulation.

Louttit C, Park KS, Moon JJ. Louttit C, et al. Biomaterials. 2019 Oct;217:119287. doi: 10.1016/j.biomaterials.2019.119287. Epub 2019 Jun 19. Biomaterials. 2019. PMID: 31247511 Free PMC article. Review.

9

Engineering Strategies to Modulate the Gut Microbiome and Immune System.

Han K, Xu J, Xie F, Crowther J, Moon JJ. Han K, et al. J Immunol. 2024 Jan 15;212(2):208-215. doi: 10.4049/jimmunol.2300480. J Immunol. 2024. PMID: 38166246 Review.

10

Vaccine nanoparticles for protection against HIV infection.

Aikins ME, Bazzill J, Moon JJ. Aikins ME, et al. Nanomedicine (Lond). 2017 Mar;12(6):673-682. doi: 10.2217/nnm-2016-0381. Epub 2017 Feb 21. Nanomedicine (Lond). 2017. PMID: 28244816 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

45 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year